Found 24 Acute Myeloid Leukemia trials
A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to compare the effects, good or bad, of idasanutlin plus cytarabine (chemotherapy) versus placebo (an inactive substance that looks like idasanutlin) plus cytarabine on patients with relapsed or refractory Acute Myeloid Leukemia (AML) to find out which is better.
An open label multi center study to assess the safety and efficacy of BST-236 as single agent in adult patients unfit for standard therapy with Acute Myeloid Leukemia (AML) or higher-risk (HR) Myelodysplastic Syndromes (MDS) who fail to respond or relapsed following first line therapy.
The purposes of this study are to see if the study drugs, venetoclax and gilteritinib can be safely and effectively combined for the treatment of patients with acute myeloid leukemia (AML) that has returned after prior treatment, or has failed to respond to prior treatment and identify potential biomarkers.
Amphivena Therapeutics, Inc. (Amphivena) is studying an investigational drug called AMV564, which may help to treat acute myeloid leukemia (AML). The purpose of this clinical research study is to find the highest tolerable dose that can be given to patients with AML, and to recommend a dose to be used …
This research is being done to see how an investigational combination of study drugs works in comparison to chemotherapy in people with acute myeloid leukemia. This study involves the following study drug combinations. You will only receive one of these combinations: • Venetoclax and azacitidine (investigational combination) • Cytarabine and …
This study investigates the use of CART-38 in adults with acute myeloid leukemia (AML) and multiple myeloma (MM).The aim is to evaluate the effects of CART-38 on these conditions. Researchers are looking at how well this treatment works and its safety for patients.Who can participate: Participants must be adults aged …
This study investigates the use of an investigational medication in combination with another medication for treating adults who have acute myeloid leukemia (AML) that has not responded to previous treatment or has returned after treatment. The purpose of the study is to find out if this combination can help in …
This is a Phase 1, first-in-human, multicenter; non-randomized, open-label and dose escalation study of AMG 176 administered IV in subjects with relapsed or refractory multiple myeloma and subjects with relapsed or refractory AML.
This study investigates a treatment for adults with acute myeloid leukemia (AML) and multiple myeloma (MM).The purpose of this study is to evaluate the effects of an investigational treatment on these conditions.Who can participate: Adults aged 18 and older diagnosed with acute myeloid leukemia or multiple myeloma may be eligible. …
This study investigates the effects of an investigational treatment in adults with acute myeloid leukemia (AML) and multiple myeloma (MM).The study aims to assess the safety and potential benefits of the investigational treatment for individuals living with these conditions.Who can participate: Adults aged 18 and older with acute myeloid leukemia …
Please choose between Voice or SMS based delivery of verification code
or